Track topics on Twitter Track topics that are important to you
POUGHKEEPSIE, NY -- (Marketwired) -- 06/06/17 -- The publisher of Laboratory Economics has just released The U.S. Anatomic Pathology Market: Forecast & Trends 2017-2020. With this special report, you can tap into 150 pages of proprietary market research that reveals critical data and information about key business trends affecting the anatomic pathology market.
The report reveals that the anatomic pathology market (including Pap testing) now represents an estimated $16 billion of revenue with an annual growth rate of 3%. With 10-year historical data and a detailed five-year forecast, all data and trends are fully explained throughout the report.
The U.S. anatomic pathology market faces challenges, including pressure on volume resulting from Medicare bundled payments for outpatient tests and greater utilization management by private payers. "However, the introduction of new higher-priced pharmacogenomic tests linked to targeted cancer drugs should more than offset price and volume pressure on routine pathology tests," according to Jondavid Klipp, Publisher of Laboratory Economics.
The report includes:
Also featured are profiles on the anatomic pathology companies: Aurora Diagnostics, Bako Integrated Physician Solutions, CellNetix Labs, LabCorp, Miraca Life Sciences, Myriad Genetics, NeoGenomics, OPKO/Bio-Reference Labs, PathGroup, Pathology Reference Laboratory, Poplar Healthcare, ProPath, Quest Diagnostics and Sonic Healthcare USA.
The U.S. Anatomic Pathology Market: Forecast & Trends 2017-2020 is published by Laboratory Economics (www.laboratoryeconomics.com), an independent market research firm focused exclusively on the business of pathology and laboratory medicine.Contact: Jondavid Klipp President Laboratory Economics 195 Kingwood Park Poughkeepsie, NY 12601 Phone: 845-463-0080 NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...